82 related articles for article (PubMed ID: 6396097)
1. Prediction of hyperkalemia associated with prolonged treatment with captopril by glucose-induced acute serum potassium changes.
Radó JP
Exp Clin Endocrinol; 1984 Oct; 84(2):143-7. PubMed ID: 6396097
[TBL] [Abstract][Full Text] [Related]
2. Interplay of various factors in glucose-induced hyperkalemia during captopril treatment.
Radó JP; Gercsák G; Bános C
Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):69-76. PubMed ID: 3514489
[TBL] [Abstract][Full Text] [Related]
3. Glucose-induced hyperkalemia developing in the upright position in captopril-treated hypertensives.
Radó JP; Bános C; Gercsák G; Molnár Z; Pató E; Csabuda M
Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):161-4. PubMed ID: 6755590
[TBL] [Abstract][Full Text] [Related]
4. Combined therapy with captopril and potassium supplementation. A potential for hyperkalemia.
Burnakis TG; Mioduch HJ
Arch Intern Med; 1984 Dec; 144(12):2371-2. PubMed ID: 6391404
[TBL] [Abstract][Full Text] [Related]
5. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
[TBL] [Abstract][Full Text] [Related]
6. Glucose-induced hyperkalemia during captopril treatment.
Radó JP
Arch Intern Med; 1983 Feb; 143(2):389. PubMed ID: 6337577
[No Abstract] [Full Text] [Related]
7. [Captopril in the treatment of essential hypertension (author's transl)].
Lederle RM; Klaus D; Braun B
Dtsch Med Wochenschr; 1980 Sep; 105(38):1307-12. PubMed ID: 6257467
[TBL] [Abstract][Full Text] [Related]
8. Glucose-induced hyperkalemia in diabetic subjects.
Nicolis GL; Kahn T; Sanchez A; Gabrilove JL
Arch Intern Med; 1981 Jan; 141(1):49-53. PubMed ID: 7447584
[TBL] [Abstract][Full Text] [Related]
9. Glucose-induced hyperkalemia in normaldosteronemic diabetes associated with hyperthyroidism.
Radó JP
Endokrinologie; 1981 Dec; 78(2-3):239-43. PubMed ID: 7037373
[TBL] [Abstract][Full Text] [Related]
10. [Sodium outflow rate through lymphocyte cell membranes, serum levels of sodium, potassium, aldosterone, total catecholamines, 6-keto- PGF2alpha and plasma renin activity in patients with primary arterial hypertension treated with captopril].
Mazurek W; Halawa B; Borejko-Słopecka G
Pol Tyg Lek; 1992 Jul 6-13; 47(27-28):588-93. PubMed ID: 1488334
[TBL] [Abstract][Full Text] [Related]
11. A possible role for human growth hormone (HGH) in the protection from glucose-induced hyperkalemia in normaldosteronemic diabetes.
Radó JP
Endokrinologie; 1982 Nov; 80(3):364-6. PubMed ID: 7166165
[TBL] [Abstract][Full Text] [Related]
12. [Long term treatment of resistant hypertension with captopril (author's transl)].
Guedon J; Chaignon M; Lucsko M; Cuche JL; Aubert P; Piete AM
Nouv Presse Med; 1981 Apr; 10(19):1565-9. PubMed ID: 7025846
[TBL] [Abstract][Full Text] [Related]
13. Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril.
Textor SC; Bravo EL; Fouad FM; Tarazi RC
Am J Med; 1982 Nov; 73(5):719-25. PubMed ID: 6291388
[TBL] [Abstract][Full Text] [Related]
14. Deterioration of renal function and hyperkalemia in hypertensive patients with impaired renal function during captopril administration.
Kodama K; Morotomi Y; Kida O; Higa T; Someya N; Kondo K; Tanaka K
Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):327-35. PubMed ID: 3894730
[No Abstract] [Full Text] [Related]
15. [Comparative effects of captopril and chlorthalidone on glucose tolerance and insulin levels essential hypertensives].
Zanella MT; Baptista M; Costa CH; Kohlmann NE; Kohlmann Júnior O; Ribeiro AB
Arq Bras Cardiol; 1996 Jul; 67(1):47-52. PubMed ID: 9035467
[TBL] [Abstract][Full Text] [Related]
16. Regulation of plasma aldosterone by glucose-induced paradoxical hyperkalemia in the presence of suppressed renin-angiotensin system.
Radó JP
Endokrinologie; 1978 Apr; 72(1):51-6. PubMed ID: 688983
[TBL] [Abstract][Full Text] [Related]
17. Neurohormonal responses to antihypertensive treatment with captopril or hydrochlorothiazide.
Rabinad E; Gaya J; Rivera F; Ingelmo M; Balcells A
Postgrad Med J; 1986; 62 Suppl 1():143-5. PubMed ID: 3534850
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)].
Di Giulio S; Perez-Ramirez JL; Jamoun P; Grünfeld JP; Meyer P
Nouv Presse Med; 1981 Apr; 10(19):1551-5. PubMed ID: 6269557
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with the angiotensin converting enzyme inhibitor captopril.
Walter NM; Whitworth JA; Kincaid-Smith P
Clin Exp Pharmacol Physiol Suppl; 1982; 7():117-21. PubMed ID: 6291829
[TBL] [Abstract][Full Text] [Related]
20. Reversal of glucose-induced hyperkalemia by sodium restriction in "normaldosteronemic" diabetes mellitus.
Radó JP
Endokrinologie; 1981 Dec; 78(2-3):244-52. PubMed ID: 7037374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
